Last reviewed 2026-04-19 · How we verify

Arthritic Pain

Approved treatments

• Salonpas
• Alphanon
• Qutenza · Averitas
• Norgesic · Endo
  Orphenadrine citrate centrally acts on brain stem to selectively block facilitatory reticular functions.
• Salonpas · Hisamitsu Pharm Co
• Acetaminophen · Polymedica
  Acetaminophen works by blocking pain signals in the brain.

Clinical guidelines

• FDA label — any
  For the temporary relief of minor aches and pains.
• FDA label — any
  For the temporary relief of minor aches and pains.
• FDA label — any
  For the temporary relief of minor aches and pains.
• FDA label — any
  For the temporary relief of minor aches and pains. Note: Aspirin is also indicated for myocardial infarction, but specific dosing and usage should be discussed with a healthcare provider.
• FDA label — any
  For the temporary relief of minor aches and pains.
• FDA label — any
  For the temporary relief of minor aches and pains.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — adj
  Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
• FDA label — 1L
  temporarily relieves minor pain of arthritis

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• Arthritic Pain patent landscape — cliff calendar, originator estates, attackable patents
• Arthritic Pain treatment landscape brief
• Arthritic Pain treatment updates RSS

Frequently asked questions about Arthritic Pain

Related

• Treatment landscape: Arthritic Pain patent cliff · Arthritic Pain CI report
• Treatment: Salonpas
• Treatment: Alphanon
• Treatment: Qutenza · Averitas
• Treatment: Norgesic · Endo
• Treatment: Salonpas · Hisamitsu Pharm Co
• All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing